A New Frontier in Phytotherapy: Harnessing the Therapeutic Power of Medicinal Herb-derived MiRNAs

Overview

Journal Curr Pharm Des

Publisher Bentham Science Publishers

Date 2024 Aug 20

PMID 39162273

Authors

Ya-Long Feng

Affiliations

Soon will be listed here.

Abstract

Medicinal herbs have been utilized in the treatment of various pathologic conditions, including neoplasms, organ fibrosis, and diabetes mellitus. However, the precise pharmacological actions of plant miRNAs in animals remain to be fully elucidated, particularly in terms of their therapeutic efficacy and mechanism of action. In this review, some important miRNAs from foods and medicinal herbs are presented. Plant miRNAs exhibit a range of pharmacological properties, such as anti-cancer, anti-fibrosis, anti-viral, anti-inflammatory effects, and neuromodulation, among others. These results have not only demonstrated a cross-species regulatory effect, but also suggested that the miRNAs from medicinal herbs are their bioactive components. This shows a promising prospect for plant miRNAs to be used as drugs. Here, the pharmacological properties of plant miRNAs and their underlying mechanisms have been highlighted, which can provide new insights for clarifying the therapeutic mechanisms of medicinal herbs and suggest a new way for developing therapeutic drugs.

References

Xiaokaiti Y, Li X . Natural Product Regulates Autophagy in Cancer. Adv Exp Med Biol. 2020; 1207:709-724. DOI: 10.1007/978-981-15-4272-5_53. View

Kashyap D, Tuli H, Yerer M, Sharma A, Sak K, Srivastava S . Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. Semin Cancer Biol. 2019; 69:5-23. DOI: 10.1016/j.semcancer.2019.08.014. View

Sflakidou E, Leonidis G, Foroglou E, Siokatas C, Sarli V . Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents. Molecules. 2022; 27(19). PMC: 9572494. DOI: 10.3390/molecules27196632. View

Hasan M, Paul N, Paul S, Saikat A, Akter H, Mandal M . Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis. Molecules. 2022; 27(5). PMC: 8911636. DOI: 10.3390/molecules27051481. View

Li J, Chen N, Ma N, Li M . Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis. Molecules. 2023; 28(23). PMC: 10707854. DOI: 10.3390/molecules28237936. View

Wang L, Li S, Yao Y, Yin W, Ye T . The role of natural products in the prevention and treatment of pulmonary fibrosis: a review. Food Funct. 2021; 12(3):990-1007. DOI: 10.1039/d0fo03001e. View

Moudgil K, Venkatesha S . The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation. Int J Mol Sci. 2023; 24(1). PMC: 9820125. DOI: 10.3390/ijms24010095. View

Fernandes A, Rodrigues P, Pintado M, Tavaria F . A systematic review of natural products for skin applications: Targeting inflammation, wound healing, and photo-aging. Phytomedicine. 2023; 115:154824. DOI: 10.1016/j.phymed.2023.154824. View

Chen C, Tsai Y, Chang W, Yang S, Hwang T . Marine Natural Product Inhibitors of Neutrophil-Associated Inflammation. Mar Drugs. 2016; 14(8). PMC: 4999902. DOI: 10.3390/md14080141. View

10.

Feng Y, Wang W, Ning Y, Chen H, Liu P . Small molecules against the origin and activation of myofibroblast for renal interstitial fibrosis therapy. Biomed Pharmacother. 2021; 139:111386. DOI: 10.1016/j.biopha.2021.111386. View

11.

Feng Y, Yang Y, Chen H . Small molecules as a source for acute kidney injury therapy. Pharmacol Ther. 2022; 237:108169. DOI: 10.1016/j.pharmthera.2022.108169. View

12.

Feng Y, Chen D, Vaziri N, Guo Y, Zhao Y . Small molecule inhibitors of epithelial-mesenchymal transition for the treatment of cancer and fibrosis. Med Res Rev. 2019; 40(1):54-78. DOI: 10.1002/med.21596. View

13.

Newman D, Cragg G . Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3):770-803. DOI: 10.1021/acs.jnatprod.9b01285. View

14.

Locke F, Rossi J, Neelapu S, Jacobson C, Miklos D, Ghobadi A . Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv. 2020; 4(19):4898-4911. PMC: 7556133. DOI: 10.1182/bloodadvances.2020002394. View

15.

Khare T, Palakurthi S, Shah B, Palakurthi S, Khare S . Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease. Int J Mol Sci. 2020; 21(11). PMC: 7312938. DOI: 10.3390/ijms21113956. View

16.

Wang Y, Sui Z, Wang M, Liu P . Natural products in attenuating renal inflammation inhibiting the NLRP3 inflammasome in diabetic kidney disease. Front Immunol. 2023; 14:1196016. PMC: 10196020. DOI: 10.3389/fimmu.2023.1196016. View

17.

Ramazani E, Akaberi M, Emami S, Tayarani-Najaran Z . Biological and Pharmacological Effects of Gamma-oryzanol: An Updated Review of the Molecular Mechanisms. Curr Pharm Des. 2020; 27(19):2299-2316. DOI: 10.2174/1381612826666201102101428. View

18.

Cheng J, Li J, Xiong R, Wu S, Xu X, Tang G . Effects and mechanisms of anti-diabetic dietary natural products: an updated review. Food Funct. 2024; 15(4):1758-1778. DOI: 10.1039/d3fo04505f. View

19.

Ramachandran V, V I, Hr K, Tiwari R, Tiwari G . Biochanin-A: A Bioactive Natural Product with Versatile Therapeutic Perspectives. Curr Drug Res Rev. 2022; 14(3):225-238. DOI: 10.2174/2589977514666220509201804. View

20.

Pinela J, Dias M, Pereira C, Alonso-Esteban J . Antioxidant Activity of Foods and Natural Products. Molecules. 2024; 29(8). PMC: 11054945. DOI: 10.3390/molecules29081814. View